Analytical characterization is vital for product quality, manufacturing control, and regulatory compliance in biopharmaceutical development. ICH Q6B outlines structural characterization requirements, ...
MUNICH, Germany—Two randomized trials testing different types of interventions for patients with acute intracerebral hemorrhage (ICH), presented here at the European Stroke Organisation Conference ...
The draft guidance ICH Q10 for pharmaceutical quality systems is part of the ongoing move to a science- and risk-based approach in manufacturing. The pharmaceutical industry's efforts to implement ...
The final ICH E6 (R3) Good Clinical Practice (GCP) Guidelines were published on 6 th January 2025, updating the framework for clinical trials to reflect modern trial designs, technology, and data ...
Intracerebral hemorrhage (ICH) is sudden, catastrophic bleeding that occurs in the brain tissue or ventricles. Symptoms may be sudden and severe, such as headache, loss of consciousness, or vomiting, ...
Good Clinical Practice (GCP), the bedrock of ethical and high-quality clinical research, guides operations among sponsor companies, contract research organisations (CROs), investigator sites, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results